1. Diffuse astrocytoma, MYB- or MYBL1-altered2. Angiocentric glioma3. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY)4. Diffuse low-grade glioma, MAPK pathway-altered. This evidence concerns the gene MYBL1 and central nervous system cancer.